An improved, convergent and industrially useful process suitable for large-scale production of Telmisartan has been described. The key steps are Suzuki coupling for the preparation of key intermediate 2-[4'-(chloromethyl)biphenyl-2-yl]-4,4-dimethyl-4,5-dihydro-1,3-oxazole of Telmisartan, N-alkylation and oxazoline hydrolysis.
Introduction
Telmisartan 1 is an angiotensin II receptor antagonist useful in the treatment of hypertension, heart diseases, heart strokes, and bladder diseases 1 . Telmisartan is currently available in the market as an antihypertensive drug 2 under the brand name of MICARDIS. The intermediate 4'-bromomethyl-biphenyl-2-carboxylic acid tert-butyl ester 5, could not be stored because of its poor stability and shorter shelf life. Therefore, it was used immediately after its preparation. Due to its high reactivity, the ester has the disadvantage of being liable to decomposition and give side reactions, thereby producing a product of low purity.
Also, N-bromosuccinimide used for the preparation of 4'-bromomethyl-biphenyl-2-carboxylic acid tert-butyl ester 5 has a disadvantage, as this unsuitable for the industrial production because of its cost and reactivity. It is also difficult to control the reaction and avoid the formation of undesired 4'-dibromomethyl-biphenyl-2-carboxylic acid tert-butyl ester 7 (dibromo impurity) (Scheme 2). 4'-bromomethyl-biphenyl-2-carboxylic acid tert-butyl ester 5, is difficult to prepare and has the disadvantages in poor working efficiency and safety, as an intermediate for industrial production. 
Results and Discussion
In our attempts to prepare Telmisartan 1, we have developed an improved three-stage process employing Suzuki-coupling 9,10 for the preparation of 2- Experimental Section General Procedures. All solvents and reagents were purchased from the commercial suppliers and used without further purification. All non-aqueous reactions were performed in dry glassware under an atmosphere of dry nitrogen. Organic solutions were concentrated under reduced pressure. Thin layer chromatography was performed on Merck precoated Silica-gel 60F 254 plates.
1 H and 13 C NMR spectra were recorded in DMSO-d 6 and CDCl 3 using 400 MHz, on a Varian Gemini 400 MHz FT NMR spectrometer. The chemical shifts were reported in δ ppm relative to TMS (Tetra methyl silane). The IR spectra were recorded in the solid state as KBr dispersion using Perkin Elmer FT-IR spectrophotometer. The mass spectra were recorded on Shimadzu LCMS-QP 800 LC-MS and AB-4000 Q-trap LC-MS/MS. Melting points were obtained by using the open capillary method and are uncorrected. 20% sodium hydroxide solution was added until the reaction mixture pH attained to 9-10 and further stirred at room temperature for 2 h. The precipitated solid was collected by filtration and washed with water (50.0 mL). The wet cake was dissolved in a mixture of water (60.0 mL) and acetonitrile (20.0 mL) and then heated to 60-65 °C. The pH of the resulting clear solution was adjusted to 5.0-5.5 using 5% acetic acid, and stirring continued for 2 h. The precipitated solid was filtered and washed with water (50 mL 
